Allied Market Research

Urinary Incontinence Devices Market Growth and Industry Analysis by 2023

Vaginal slings gain significant traction over the years and preference for vaginal sling procedures among the patients suffering from urinary incontinence has witnessed an increase in recent years. With changes in lifestyle and its complications, the incidence of female stress urinary incontinence has escalated among developed countries boosting the market growth. Increase in investment by manufacturers in the development of single incision vaginal slings such as MiniArc manufactured by American Medical Systems (AMS), and Adjust mini sling manufactured by C.R. BARD will offer lucrative opportunities for the expansion of the market growth.


Portland, OR -- (SBWIRE) -- 06/14/2018 -- According to a new report published by Allied Market Research, titled, Urinary Incontinence Devices Market by Product, Category, Incontinence Type, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023, the urinary incontinence devices market was valued at $1,611 million in 2016, and is projected to reach $3,411 million by 2023, growing at a CAGR of 11.3% from 2017 to 2023. The internal urinary incontinence devices segment accounted for three-fifths share of the market in 2016.

Access Full Summary at :

Urinary incontinence is a highly prevalent condition and is considered to be an underreported problem that increases with age that affects nearly 50% of the geriatric population. Urinary incontinence is categorized into four major types namely stress urinary incontinence, urge urinary incontinence, mixed urinary incontinence, and functional urinary incontinence. Stress urine leakage is associated with increased abdominal pressure from laughing, sneezing, coughing, climbing stairs, or other physical factors that assert stress on the abdominal cavity. Whereas, urge incontinence is the involuntary leakage accompanied by urgency. Among the four above mentioned types of urinary incontinence, stress and urge are most commonly prevalent among men and women.

Urinary incontinence has a major impact on the emotional, psychological, and social life; maximum number of patients suffering from urinary incontinence cannot perform regular activities confidently. This propels the development of effective solutions for the treatment of the same. According to the Urology Care Foundation, a quarter to a third of men and women in the U.S. suffer from urinary incontinence per year. This also indicates that approximately 33 million of the U.S. residents have overactive bladder that represent symptoms of urgency and frequency leading to the urge in the usage of urinary incontinence devices.

Some of the other factors responsible for substantial market growth include development of innovative urinary incontinence devices, increase in aging population coupled with high risk of urological conditions, and increase in the urinary incontinent patients transitioning from conventional solutions to advanced surgical treatments. Factors such as lack of awareness regarding novel developments in the urinary incontinence devices and post-operative complications associated with the devices restrict the market growth to a certain extent. Moreover, growth in healthcare expenditures in the developing economies offers lucrative opportunities for the market players to invest in these economies.

Vaginal slings generated the highest revenue in 2016, accounting for about two-fifths of the total market. This is attributed to the high contribution of the conventional vaginal slings in the vaginal slings market owing to the high preference for the use of biomaterials in surgical treatment of incontinence. Advancements in the conventional vaginal slings assist in eliminating the post-operative complications associated with the vaginal sling surgeries and several key players are developing conventional slings using advanced synthetic materials to meet the patients requirement. In addition, the advanced vaginal slings have witnessed increased adoption in the surgical treatment of urinary incontinence among women owing to their minimal invasive nature.

Based on incontinence type, stress incontinence generated the highest revenue in 2016 accounting for about half of the total share of the market and is anticipated to continue this trend throughout the forecast period. Pregnancy as well as childbirth result in the stretching and weakening of a womans pelvic floor muscles which causes stress urinary incontinence. In addition, prostate surgeries in men can also result in stress urinary incontinence. This has made stress urinary incontinence the most prevalent conditions among men and women.

Key Findings of the Urinary Incontinence Devices Market:
1. The Internal urinary incontinence devices segment generated the highest revenue in 2016 and is anticipated to do so throughout the forecast period, registering a CAGR of 12.3% from 2017 to 2023.
2. Hospitals dominated the end user market, accounting for maximum share in global market in 2016 and is expected to witness a CAGR of 10.1% from 2017 to 2023.
3. North America dominated the market, accounting for maximum share in 2016 and is expected to retain the same trend during 2017 to 2023.
4. Japan accounted for two-sevenths share of the Asia-Pacific urinary incontinence devices market in 2016.

Asia-Pacific is expected to witness the highest growth rate for urinary incontinence devices market throughout the forecast period. Asia-Pacific offers lucrative opportunities for players that operate in the urinary incontinence devices market due to its high population base, growth in disposable incomes, and improvement in patient awareness about advanced urinary incontinence management. Japan, India, and China are among the leading countries for prevalence of urinary incontinence in Asia-Pacific, which further contributes to the robust growth displayed by this region in the global market

The key players in this market have adopted product launch as one of their key developmental strategies such as acquisitions and product launches. The major companies profiled in this report include Coloplast, Boston Scientific Corporation, C. R. Bard, Inc., ConvaTec Group Plc, Ethicon, Inc., Caldera Medical Inc, Cook Medical, Covidien plc (Medtronic), Prosurg, Inc., and Cogentix Medical Inc. Other players (profiles not included in the report) in the value chain analysis include, Sofradim, B Braun Melsungen AG, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Karl Storz GmbH & Co. KG, Nipro Corporation, Olympus Corporation, ABISS, and Betatech Medical.

Request Sample Copy of This Report at: